Why Citigroup Placed An $85 Price Target On Shares Of Alkermes By: Benzinga via Benzinga January 14, 2015 at 14:37 PM EST Citigroups' Jonathan Eckard, Ph.D. continues to believe that Alkermes Plc (NASDAQ: ALKS) is a top name among biotech stocks and ... Read More >> Related Stocks: Alkermes Plc